PH30889A - Dna encoding equuine-gamma interferon and recombination production of equine ifn-polypeptides. - Google Patents
Dna encoding equuine-gamma interferon and recombination production of equine ifn-polypeptides.Info
- Publication number
- PH30889A PH30889A PH36200A PH36200A PH30889A PH 30889 A PH30889 A PH 30889A PH 36200 A PH36200 A PH 36200A PH 36200 A PH36200 A PH 36200A PH 30889 A PH30889 A PH 30889A
- Authority
- PH
- Philippines
- Prior art keywords
- equine
- polypeptides
- equuine
- ifn
- dna encoding
- Prior art date
Links
- 229920001184 polypeptide Polymers 0.000 title abstract 4
- 241000283073 Equus caballus Species 0.000 title abstract 2
- 229940044627 gamma-interferon Drugs 0.000 title 1
- 230000006798 recombination Effects 0.000 title 1
- 238000005215 recombination Methods 0.000 title 1
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 3
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 3
- 108091028043 Nucleic acid sequence Proteins 0.000 abstract 2
- 108020004414 DNA Proteins 0.000 abstract 1
- 102000008070 Interferon-gamma Human genes 0.000 abstract 1
- 108010074328 Interferon-gamma Proteins 0.000 abstract 1
- 229960003130 interferon gamma Drugs 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
- 239000013598 vector Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
- C07K16/249—Interferons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/555—Interferons [IFN]
- C07K14/57—IFN-gamma
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Toxicology (AREA)
- Immunology (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19863642096 DE3642096A1 (de) | 1986-12-10 | 1986-12-10 | Pferde-(gamma)-interferon |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PH30889A true PH30889A (en) | 1997-12-23 |
Family
ID=6315829
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PH36200A PH30889A (en) | 1986-12-10 | 1987-12-10 | Dna encoding equuine-gamma interferon and recombination production of equine ifn-polypeptides. |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US5602010A (pt) |
| EP (1) | EP0271824B1 (pt) |
| JP (3) | JPS63233794A (pt) |
| KR (1) | KR880007568A (pt) |
| AT (1) | ATE91722T1 (pt) |
| AU (1) | AU616873B2 (pt) |
| CA (1) | CA1339776C (pt) |
| DE (2) | DE3642096A1 (pt) |
| DK (1) | DK170054B1 (pt) |
| ES (1) | ES2058094T3 (pt) |
| FI (1) | FI99116C (pt) |
| HU (1) | HU213566B (pt) |
| IE (1) | IE60404B1 (pt) |
| IL (1) | IL84780A (pt) |
| NO (1) | NO180239C (pt) |
| NZ (1) | NZ222856A (pt) |
| PH (1) | PH30889A (pt) |
| PT (1) | PT86332B (pt) |
| SU (1) | SU1701114A3 (pt) |
| ZA (1) | ZA879245B (pt) |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FI88175C (fi) | 1980-04-03 | 1993-04-13 | Biogen Inc | Rekombinant-dna-molekyler och foerfaranden foer framstaellning av polypeptider liknande humant -interferon |
| US6307025B1 (en) | 1989-04-28 | 2001-10-23 | Biogen, Inc. | VCAM fusion proteins and DNA coding therefor |
| US5272263A (en) * | 1989-04-28 | 1993-12-21 | Biogen, Inc. | DNA sequences encoding vascular cell adhesion molecules (VCAMS) |
| US7049102B1 (en) | 1989-09-22 | 2006-05-23 | Board Of Trustees Of Leland Stanford University | Multi-gene expression profile |
| GB9414752D0 (en) * | 1994-07-21 | 1994-09-07 | Q One Biotech Ltd | Feline gamma-interferon |
| GB2291645A (en) * | 1994-07-21 | 1996-01-31 | Q One Biotech Ltd | Equine gamma-interferon |
| AU2587002A (en) * | 2000-11-03 | 2002-05-15 | Biomedicines Inc | Method for short-term and long-term drug dosimetry |
| KR20040053291A (ko) * | 2001-11-09 | 2004-06-23 | 바이오메디신즈 인코포레이티드 | 오메가 인터페론을 이용한 질환 치료 방법 |
| US7731947B2 (en) | 2003-11-17 | 2010-06-08 | Intarcia Therapeutics, Inc. | Composition and dosage form comprising an interferon particle formulation and suspending vehicle |
| US11246913B2 (en) | 2005-02-03 | 2022-02-15 | Intarcia Therapeutics, Inc. | Suspension formulation comprising an insulinotropic peptide |
| WO2006083761A2 (en) | 2005-02-03 | 2006-08-10 | Alza Corporation | Solvent/polymer solutions as suspension vehicles |
| MX2008014870A (es) | 2006-05-30 | 2009-02-12 | Intarcia Therapeutics Inc | Modulador de flujo para sistema de suministro osmotico con canal interno de dos piezas. |
| MX2009001114A (es) | 2006-08-09 | 2009-02-10 | Intarcia Therapeutics Inc | Sistemas de suministro osmotico y ensambles de piston. |
| CN104000779A (zh) | 2007-04-23 | 2014-08-27 | 精达制药公司 | 促胰岛素释放肽的混悬制剂及其应用 |
| CA2726861C (en) | 2008-02-13 | 2014-05-27 | Intarcia Therapeutics, Inc. | Devices, formulations, and methods for delivery of multiple beneficial agents |
| DK2462246T3 (da) | 2009-09-28 | 2017-11-06 | Intarcia Therapeutics Inc | Hurtig etablering og/eller afslutning af væsentlig steady-state-lægemiddelafgivelse |
| US20120208755A1 (en) | 2011-02-16 | 2012-08-16 | Intarcia Therapeutics, Inc. | Compositions, Devices and Methods of Use Thereof for the Treatment of Cancers |
| US9889085B1 (en) | 2014-09-30 | 2018-02-13 | Intarcia Therapeutics, Inc. | Therapeutic methods for the treatment of diabetes and related conditions for patients with high baseline HbA1c |
| US10925639B2 (en) | 2015-06-03 | 2021-02-23 | Intarcia Therapeutics, Inc. | Implant placement and removal systems |
| MA53353A (fr) | 2016-05-16 | 2021-06-09 | Intarcia Therapeutics Inc | Polypeptides sélectifs pour le récepteur du glucagon et méthodes pour leur utilisation |
| USD840030S1 (en) | 2016-06-02 | 2019-02-05 | Intarcia Therapeutics, Inc. | Implant placement guide |
| USD860451S1 (en) | 2016-06-02 | 2019-09-17 | Intarcia Therapeutics, Inc. | Implant removal tool |
| KR20190104039A (ko) | 2017-01-03 | 2019-09-05 | 인타르시아 세라퓨틱스 인코포레이티드 | Glp-1 수용체 효능제의 연속적인 투여 및 약물의 동시-투여를 포함하는 방법 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE88622C (pt) * | ||||
| ZA811368B (en) * | 1980-03-24 | 1982-04-28 | Genentech Inc | Bacterial polypedtide expression employing tryptophan promoter-operator |
| ZA831094B (en) * | 1982-02-22 | 1983-11-30 | Biogen Nv | Dna sequences,recombinant dna molecules and processes for producing human immune interferon-like polypeptides |
| IE54592B1 (en) * | 1982-03-08 | 1989-12-06 | Genentech Inc | Anumal interferons, processes involved in their production, compositions containing them, dna sequences coding therefor and espression vehicles containing such sequences and cells transformed thereby |
| DE3247922A1 (de) * | 1982-12-24 | 1984-06-28 | Boehringer Ingelheim International GmbH, 6507 Ingelheim | Dna-sequenzen, deren herstellung, diese sequenzen enthaltende plasmide und deren verwendung zur synthese eukaryotischer genprodukte in prokaryoten |
| JPS60118196A (ja) * | 1983-11-30 | 1985-06-25 | Takeda Chem Ind Ltd | インタ−フェロンの製造法 |
| US4666865A (en) * | 1984-01-13 | 1987-05-19 | Centocor, Inc. | Immunoassay for biologically active human interferon-gamma employing unique monoclonal antibodies |
| DE3414831A1 (de) * | 1984-04-19 | 1985-10-31 | Hoechst Ag, 6230 Frankfurt | Herstellung von polypeptiden mit human-gammainterferon-aktivitaet |
| FI90990C (fi) * | 1984-12-18 | 1994-04-25 | Boehringer Ingelheim Int | Rekombinantti-DNA-molekyyli, transformoitu isäntäorganismi ja menetelmä interferonin valmistamiseksi |
| US4689224A (en) * | 1985-10-07 | 1987-08-25 | Neogen Corporation | Method for administering vaccines containing equine leukokines and compositions therefor |
| DE3607835A1 (de) * | 1986-03-10 | 1987-09-24 | Boehringer Ingelheim Int | Hybridinterferone, deren verwendung als arzneimittel und als zwischenprodukte zur herstellung von antikoerpern und deren verwendung sowie verfahren zu ihrer herstellung |
| CA1340698C (en) * | 1986-07-25 | 1999-08-10 | Kabushiki Kaisha Hayashibara Seibutsu Kaguku Kenkyujo | Preparation and uses of interferon-gamma |
| US4908432A (en) * | 1987-01-09 | 1990-03-13 | New York University | Novel polypeptide having gamma-interferon activity |
-
1986
- 1986-12-10 DE DE19863642096 patent/DE3642096A1/de not_active Ceased
-
1987
- 1987-12-08 AU AU82233/87A patent/AU616873B2/en not_active Ceased
- 1987-12-09 EP EP87118264A patent/EP0271824B1/de not_active Expired - Lifetime
- 1987-12-09 DK DK645887A patent/DK170054B1/da not_active IP Right Cessation
- 1987-12-09 ZA ZA879245A patent/ZA879245B/xx unknown
- 1987-12-09 DE DE8787118264T patent/DE3786649D1/de not_active Expired - Fee Related
- 1987-12-09 ES ES87118264T patent/ES2058094T3/es not_active Expired - Lifetime
- 1987-12-09 SU SU874203834A patent/SU1701114A3/ru active
- 1987-12-09 CA CA000553890A patent/CA1339776C/en not_active Expired - Fee Related
- 1987-12-09 NZ NZ222856A patent/NZ222856A/xx unknown
- 1987-12-09 AT AT87118264T patent/ATE91722T1/de not_active IP Right Cessation
- 1987-12-09 IE IE334287A patent/IE60404B1/en not_active IP Right Cessation
- 1987-12-09 HU HU875549A patent/HU213566B/hu not_active IP Right Cessation
- 1987-12-09 NO NO875136A patent/NO180239C/no unknown
- 1987-12-10 PT PT86332A patent/PT86332B/pt not_active IP Right Cessation
- 1987-12-10 JP JP62313130A patent/JPS63233794A/ja active Pending
- 1987-12-10 IL IL84780A patent/IL84780A/xx not_active IP Right Cessation
- 1987-12-10 PH PH36200A patent/PH30889A/en unknown
- 1987-12-10 KR KR870014068A patent/KR880007568A/ko not_active Ceased
- 1987-12-10 FI FI875427A patent/FI99116C/fi not_active IP Right Cessation
-
1994
- 1994-06-17 US US08/263,214 patent/US5602010A/en not_active Expired - Fee Related
- 1994-12-12 JP JP6307980A patent/JPH07258294A/ja active Pending
- 1994-12-12 JP JP6307981A patent/JPH07250690A/ja active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PH30889A (en) | Dna encoding equuine-gamma interferon and recombination production of equine ifn-polypeptides. | |
| EP0174367A4 (en) | HOSTS AND METHODS FOR PRODUCING RECOMBINANT PRODUCTS IN LARGE QUANTITIES. | |
| GB2197324B (en) | Process for the production of a polypeptide | |
| HUT46061A (en) | Dna sequences encoding hirudin-like protein and process for producing such proteins | |
| YU233582A (en) | Process for the expression of a gene coded for human imunological interferon | |
| DE3479321D1 (en) | Biosynthetically produced human nerve growth factor, process for producing it, compositions containing it, dna sequence encoding it, vectors containing the sequence and host cells transformed thereby | |
| HUT43629A (en) | Process for producing fusion proteins | |
| NZ222450A (en) | Synthetic dna, peptide synthesis and regulation of transcription of silk like protein | |
| CA2066370A1 (en) | Yield when disulfide-bonded proteins are secreted | |
| DK164940C (da) | Polypeptid med human-gamma-interferonaktivitet, genteknologisk fremgangsmaade til fremstilling deraf, hybrid-plasmider indeholdende en dna-sekvens, der koder for peptidet, vaertsorganismer indeholdende hybridplasmiderne, samt laegemidler, som indeholder polypeptidet | |
| EP0268772A3 (en) | Expression of biologically active factor xiii | |
| NO177570B (no) | Fremgangsmåte ved fremstilling av peptider med fibronektinbindende egenskaper, mikroorganisme og DNA-sekvens som koder for peptider med fibronektinbindende egenskaper | |
| ES8107307A1 (es) | Un procedimiento de preparacion de un vector de transferen- cia de adn | |
| EP0222279A3 (en) | Production of active proteins containing cystine residues | |
| EP0146903A3 (en) | Production of a vector encoding a novel hybrid interferon species | |
| GB8701848D0 (en) | Polypeptides | |
| IL82962A0 (en) | Dna sequences containing a light inducible promoter derived from a myxobacterium and process for preparing polypeptides | |
| EP0238275A3 (en) | Recombinant product | |
| IL78278A0 (en) | Process for the production of polypeptides,dna sequence encoding desired polypeptide human somatomedin c polypeptide and recombinant dna molecules | |
| EP0367641A3 (en) | Lymphokines, dna sequences encoding these lymphokines and pharmaceutical compositions containing these lymphokines |